Dr. Cohen-Dayag joined Compugen in 2002. She has held various positions, including Vice President, R&D and co-CEO. In 2010, Dr. Cohen-Dayag was appointed as Compugen’s President and CEO. She joined Compugen’s Board of Directors in 2014. Dr. Cohen- Dayag holds a BSc in biology from the Ben-Gurion University, and an MSc in chemical immunology as well as a Ph.D. in cellular biology, both from the Weizmann Institute of Science. Dr. Cohen- Dayag is a director of the Israeli Advanced Technologies Industries.
.svg)
